989 related articles for article (PubMed ID: 33312177)
1. Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia.
Griggio V; Perutelli F; Salvetti C; Boccellato E; Boccadoro M; Vitale C; Coscia M
Front Immunol; 2020; 11():594556. PubMed ID: 33312177
[TBL] [Abstract][Full Text] [Related]
2. NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications.
Sportoletti P; De Falco F; Del Papa B; Baldoni S; Guarente V; Marra A; Dorillo E; Rompietti C; Adamo FM; Ruggeri L; Di Ianni M; Rosati E
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206399
[TBL] [Abstract][Full Text] [Related]
3. Novel Therapies in Chronic Lymphocytic Leukemia: A Rapidly Changing Landscape.
Iovino L; Shadman M
Curr Treat Options Oncol; 2020 Mar; 21(4):24. PubMed ID: 32170458
[TBL] [Abstract][Full Text] [Related]
4. T Cells in Chronic Lymphocytic Leukemia: A Two-Edged Sword.
Vlachonikola E; Stamatopoulos K; Chatzidimitriou A
Front Immunol; 2020; 11():612244. PubMed ID: 33552073
[TBL] [Abstract][Full Text] [Related]
5. Cellular immune therapy for chronic lymphocytic leukemia.
Kater AP; van Oers MH; Kipps TJ
Blood; 2007 Oct; 110(8):2811-8. PubMed ID: 17638850
[TBL] [Abstract][Full Text] [Related]
6. Engaging Cytotoxic T and NK Cells for Immunotherapy in Chronic Lymphocytic Leukemia.
Hofland T; Eldering E; Kater AP; Tonino SH
Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31484424
[TBL] [Abstract][Full Text] [Related]
7. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment.
Hallek M
Am J Hematol; 2019 Nov; 94(11):1266-1287. PubMed ID: 31364186
[TBL] [Abstract][Full Text] [Related]
8. Chimeric Antigen Receptor T Cells in Chronic Lymphocytic Leukemia: Are We Any Closer to a Cure?
Rhodes JM; Schuster SJ
Cancer J; 2019; 25(6):436-441. PubMed ID: 31764125
[TBL] [Abstract][Full Text] [Related]
9. Advances in chimeric antigen receptor immunotherapy for chronic lymphocytic leukemia.
Riches JC; Gribben JG
Discov Med; 2013 Dec; 16(90):295-302. PubMed ID: 24333409
[TBL] [Abstract][Full Text] [Related]
10. Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental Conditions.
Arruga F; Gyau BB; Iannello A; Vitale N; Vaisitti T; Deaglio S
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32155826
[TBL] [Abstract][Full Text] [Related]
11. Improving therapy of chronic lymphocytic leukemia with chimeric antigen receptor T cells.
Fraietta JA; Schwab RD; Maus MV
Semin Oncol; 2016 Apr; 43(2):291-9. PubMed ID: 27040708
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapeutic Strategies in Chronic Lymphocytic Leukemia: Advances and Challenges.
Perutelli F; Jones R; Griggio V; Vitale C; Coscia M
Front Oncol; 2022; 12():837531. PubMed ID: 35265527
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulation and immune reconstitution in chronic lymphocytic leukemia.
Riches JC; Gribben JG
Semin Hematol; 2014 Jul; 51(3):228-34. PubMed ID: 25048786
[TBL] [Abstract][Full Text] [Related]
14. Vaccine- and immune-based therapy in chronic lymphocytic leukemia.
Le Dieu R; Gribben J
Semin Oncol; 2006 Apr; 33(2):220-9. PubMed ID: 16616069
[TBL] [Abstract][Full Text] [Related]
15. Tailored Treatment Strategies for Chronic Lymphocytic Leukemia in a Rapidly Changing Era.
Brander D; Islam P; Barrientos JC
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():487-498. PubMed ID: 31099686
[TBL] [Abstract][Full Text] [Related]
16. HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL).
Kowalewski DJ; Schuster H; Backert L; Berlin C; Kahn S; Kanz L; Salih HR; Rammensee HG; Stevanovic S; Stickel JS
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):E166-75. PubMed ID: 25548167
[TBL] [Abstract][Full Text] [Related]
17. Ibrutinib for improved chimeric antigen receptor T-cell production for chronic lymphocytic leukemia patients.
Fan F; Yoo HJ; Stock S; Wang L; Liu Y; Schubert ML; Wang S; Neuber B; Hückelhoven-Krauss A; Gern U; Schmitt A; Müller-Tidow C; Dreger P; Schmitt M; Sellner L
Int J Cancer; 2021 Jan; 148(2):419-428. PubMed ID: 32683672
[TBL] [Abstract][Full Text] [Related]
18. Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures.
Hallek M; Al-Sawaf O
Am J Hematol; 2021 Dec; 96(12):1679-1705. PubMed ID: 34625994
[TBL] [Abstract][Full Text] [Related]
19. T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers.
Palma M; Gentilcore G; Heimersson K; Mozaffari F; Näsman-Glaser B; Young E; Rosenquist R; Hansson L; Österborg A; Mellstedt H
Haematologica; 2017 Mar; 102(3):562-572. PubMed ID: 27927767
[TBL] [Abstract][Full Text] [Related]
20. New insights into hematopoietic stem cell transplantation for chronic lymphocytic leukemia: a 2015 perspective.
McClanahan F; Gribben J
Clin Adv Hematol Oncol; 2015 Sep; 13(9):586-94. PubMed ID: 26452190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]